VerAvanti Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 12


  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $993K

  • Investors
  • 3

VerAvanti General Information


Developer of a scanning fiber endoscope device designed to identify the causes of strokes and cardiac events. The company's device consists of an imaging station and a tiny catheter that is designed to take high-definition images, thereby enabling doctors and surgeons to have a peek into hidden intra-vascular anatomy and visually identify potential risks for stroke and cardiovascular risks.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 2260 152nd Avenue Northeast
  • Suite 200
  • Redmond, WA 98052
  • United States
+1 (425) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VerAvanti Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 23-Sep-2021 $993K 00.000 Completed Startup
6. Debt - PPP 29-Apr-2020 00.000 Completed Startup
5. Capitalization 17-Jul-2017 000 00.000 Completed Startup
4. Grant 01-Jun-2017 00000 00000 Completed Startup
3. Angel (individual) 25-May-2017 00000 00000 Completed Startup
2. Accelerator/Incubator 28-Jun-2014 Completed Startup
1. Spin-Off 01-Jan-2013 Completed Startup
To view VerAvanti’s complete valuation and funding history, request access »

VerAvanti Patents

VerAvanti Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2023514816-A Forward-looking rgb/optical coherence tomography dual imager Active 30-Jan-2020 00000000000
US-11530910-B2 Forward looking rgb/optical coherence tomography duplex imager Active 30-Jan-2020 00000000000 000
US-11047671-B1 Forward looking rgb/optical coherence tomography duplex imager Active 30-Jan-2020 00000000000 000
US-20210239451-A1 Forward looking rgb/optical coherence tomography duplex imager Active 30-Jan-2020 00000000000 0
US-20230184536-A1 Synchronizing an optical coherence tomography system Pending 30-Jan-2020 G01B9/02091
To view VerAvanti’s complete patent history, request access »

VerAvanti Executive Team (3)

Name Title Board Seat Contact Info
Gerald McMorrow Founder, Chief Executive Officer & Board Member
Luis Savastano Chief Medical Officer
You’re viewing 2 of 3 executive team members. Get the full list »

VerAvanti Board Members (3)

Name Representing Role Since
David Auth Ph.D Self Board Member 000 0000
Frederic Moll MD Self Board Member 000 0000
Gerald McMorrow VerAvanti Founder, Chief Executive Officer & Board Member 000 0000
To view VerAvanti’s complete board members history, request access »

VerAvanti Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VerAvanti Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Cancer Institute Government 000 0000 000000 0
National Heart, Lung, and Blood Institute Government 000 0000 000000 0
UW CoMotion Accelerator/Incubator 000 0000 000000 0
To view VerAvanti’s complete investors history, request access »

VerAvanti FAQs

  • When was VerAvanti founded?

    VerAvanti was founded in 2013.

  • Who is the founder of VerAvanti?

    Gerald McMorrow is the founder of VerAvanti.

  • Who is the CEO of VerAvanti?

    Gerald McMorrow is the CEO of VerAvanti.

  • Where is VerAvanti headquartered?

    VerAvanti is headquartered in Redmond, WA.

  • What is the size of VerAvanti?

    VerAvanti has 12 total employees.

  • What industry is VerAvanti in?

    VerAvanti’s primary industry is Diagnostic Equipment.

  • Is VerAvanti a private or public company?

    VerAvanti is a Private company.

  • What is VerAvanti’s current revenue?

    The current revenue for VerAvanti is 00000.

  • How much funding has VerAvanti raised over time?

    VerAvanti has raised $5.54M.

  • Who are VerAvanti’s investors?

    National Cancer Institute, National Heart, Lung, and Blood Institute, and UW CoMotion have invested in VerAvanti.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »